Tag: FDA

This Begins at Home: The Impact of American Political Discourse on Global Gender Equality

| February 2, 2013 | 0 Comments
This Begins at Home: The Impact of American Political Discourse on Global Gender Equality

The topic of gender and global health is in vogue. For an American, it is exciting to work abroad, exhilarating to work for change where there exists low hanging fruit (advocating for women to have the right to divorce, own land, drive, obtain an education). It is easy for a Westerner to condemn laws or practices that affect women living in different lands, subjected to extremes that patently subordinate them (stoning women for perceived adultery, condoning rape that occurs within a relationship, banishing women that suffer fistulas during childbirth)…

Continue Reading

Funding Orphan Drugs: Pitfalls of the Orphan Drug Act

| October 19, 2012 | 0 Comments
Funding Orphan Drugs: Pitfalls of the Orphan Drug Act

The debate over cost and access to drugs has long raged between patients, health advocates, and pharmaceutical companies. For patients with “orphan diseases,” or rare diseases which affect fewer than 200,000 people in the United States, this debate becomes particularly acute, as the Orphan Drug Act passed by Congress in 1983 threatens to drive up prices for highly specialized treatments. While the Orphan Drug Act has helped to bring drugs for rare diseases to millions of patients and continues to stimulate research and development of orphan drugs, the law is certainly not without its problems and caveats.

Continue Reading

Sasha and Malia Versus the FDA

| February 29, 2012 | 0 Comments
Sasha and Malia Versus the FDA

Access to reproductive healthcare is an inflammatory subject matter, often discussed in ideological rather than medical terms. Its attachment to sexuality and social norms distracts the public, legislators, and the judiciary from the de facto result of confounding morality with medicine. In other words, notions of virtue are relevant to families, not the state, and replacing evidence-based policy with dogma leaves women without care, regardless of the circumstances that placed them in need.

Continue Reading